Spectral Medical and partner Vantive are ploughing ahead with an application for the approval of their endotoxic septic shock therapy after it exceeded expectations in a Phase III trial. In topline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback